NasdaqGS - Nasdaq Real Time Price USD
AnaptysBio, Inc. (ANAB)
21.63
+1.32
+(6.50%)
As of 1:13 PM EST. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
25.4
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| QTRX Quanterix Corporation | 25 | -- | -- | -- |
| PLRX Pliant Therapeutics, Inc. | 25 | -- | -- | -- |
| ANAB AnaptysBio, Inc. | 25 | -- | -- | -- |
| STOK Stoke Therapeutics, Inc. | 25 | -- | -- | -- |
| KZR Kezar Life Sciences, Inc. | 25 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 11/2024
ANAB
Category Average
N/A None Controversy Level
None 4 Severe
-- ANAB
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
XNCR Xencor, Inc.
24.11
+1.64%
SYRE Spyre Therapeutics, Inc.
27.10
-1.47%
PLRX Pliant Therapeutics, Inc.
13.21
+3.73%
NAMS NewAmsterdam Pharma Company N.V.
20.36
+1.75%
PRTA Prothena Corporation plc
14.55
+1.04%
NUVL Nuvalent, Inc.
93.41
+2.46%
ALMS Alumis Inc.
9.69
+0.52%
NRIX Nurix Therapeutics, Inc.
23.07
+1.92%
PTGX Protagonist Therapeutics, Inc.
42.56
+4.70%
ORIC ORIC Pharmaceuticals, Inc.
8.95
+2.40%